Novel Drug Reduced Proteinuria by 46% in IgA Nephropathy Trial

(MedPage Today) — At the American Society of Nephrology Kidney Week meeting, interim results from the phase III ORIGIN 3 trial showed that investigational atacicept led to a 46% reduction in proteinuria at 36 weeks in patients with immunoglobulin…